Holen Sie sich die Stockscreener-App
4.99
25.38%
1.01
Handel nachbörslich:
4.70
-0.29
-5.81%
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Adial Pharmaceuticals Releases Q2 2026 Financial Results - news.alphastreet.com
Adial Closes $32M Tranche of $64M Financing for Ulcerative Colitis Drug Development - Minichart
Form 8K Adial Pharmaceuticals Inc For: 17 August By Investing.com - Investing.com Canada
Weekly Recap: Cash shortfall, warrant reliance and CEO succession, CFO exit - TradingView
Adial Reports $52 Million Second-Quarter Net Loss After Azora Acquisition - Quiver Quantitative
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update - The Manila Times
A $46.2M Noncash Charge Hit Adial’s Latest Quarter—Why? - Stock Titan
Adial Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Adial Pharmaceuticals (NASDAQ: ADIL) lifts cash to $28.7M but flags going‑concern risk - Stock Titan
Form 8K Adial Pharmaceuticals Inc For: 13 August By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals plans leadership changes tied to annual meeting vote - Investing.com
Adial Pharmaceuticals Plans Major Leadership and Board Transition - TipRanks
Adial PharmaceuticalsAs Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting - TradingView
Adial Pharmaceuticals Inc (ADIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Adial Pharmaceuticals Acquires Azora Therapeutics in Stock-and-Preferred Deal - Minichart
Adial Pharmaceuticals announces annual shareholder meeting - Bitget
Form 8K Adial Pharmaceuticals Inc For: 11 August By Investing.com - Investing.com Canada
Adial Pharmaceuticals (NASDAQ: ADIL) outlines Azora merger, heavy dilution and $53M share overhang - Stock Titan
Adial Pharmaceuticals Inc expected to post a loss of $1.03 a shareEarnings Preview - TradingView
Adial Pharmaceuticals Price Target Announced at $11.00/Share by Alliance Global Partners - Moomoo
Adial Pharmaceuticals Initiated at Buy by Alliance Global Partners - Moomoo
A. G. P. Initiates Adial Pharmaceuticals(ADIL.US) With Buy Rating, Announces Target Price $11 - moomoo.com
Adial Pharmaceuticals Inc (ADIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Adial Pharmaceuticals Inc (ADIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Adial Pharmaceuticals Inc (ADIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adial Pharmaceuticals Inc (ADIL) Institutional Confidence - TradingKey
Adial Pharmaceuticals Inc (ADIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ADIL|Adial Pharmaceuticals Inc|Price:2.860|Chg%:+0.080 - TradingKey
Adial Pharmaceuticals Inc (ADIL) Cash Flow - tradingkey.com
ADIL|Adial Pharmaceuticals Inc|Price:4.400|Chg%:+0.090 - TradingKey
Adial Pharmaceuticals, Inc Revenue Breakdown – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals (ADIL) Slides 1.09% as Stock Tests Key Support ZoneExhaustion Gap - dars.gov.et
Adial Pharmaceuticals (ADIL) Edges Higher as Shares Test Key Resistance ZoneVolume Profile - dars.gov.et
Adial Pharmaceuticals (ADIL) Slides 3.57%: Testing Key Support Near $2.56Accumulation Line - dars.gov.et
Form 4 Adial Pharmaceuticals Inc For: 16 July By Investing.com - Investing.com South Africa
Coastlands Capital buys $8,690 of Adial Pharmaceuticals stock By Investing.com - Investing.com Nigeria
Coastlands Capital buys $8,690 of Adial Pharmaceuticals stock - Investing.com
Coastlands Capital (NASDAQ: ADIL) buys 3,233 ADIAL shares in open market - Stock Titan
Adial Pharmaceuticals (ADIL) Edges Higher on Potential Breakout Above Key ResistanceInside Day Breakout - dars.gov.et
Adial Pharmaceuticals Inc (ADIL) Q1 2026 Earnings: Narrower Loss Than Expected Boosts SharesSaaS Earnings Trends - dars.gov.et
Form 4 Adial Pharmaceuticals Inc For: 13 July By Investing.com - Investing.com Nigeria
10% owner Coastlands Capital buys $32,637 in Adial Pharmaceuticals By Investing.com - Investing.com Nigeria
10% owner Coastlands Capital buys $32,637 in Adial Pharmaceuticals - Investing.com
Coastlands Capital LP (NASDAQ: ADIL) reports new insider share purchases - Stock Titan
Adial Pharmaceuticals (ADIL) Stock Forecast & Analyst Ratings - Moomoo
Adial Pharmaceuticals (ADIL) Hovers Near Support as Biotech Sector Faces PressureRating Change - Bölüm Sonu Canavarı
Price to earnings forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals Inc (ADIL) Reclaims Ground: Up 3.20% to $2.9Wave Extension - dars.gov.et
Price to sales forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Group takes 14.22% position in Adial Pharmaceuticals (ADIL) - Stock Titan
Enterprise value to EBIT forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals By Investing.com - Investing.com Nigeria
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals - Investing.com
Form 4 Adial Pharmaceuticals Inc For: 1 July By Investing.com - Investing.com Canada
Adial Pharmaceuticals (ADIL) holder Coastlands Capital adds 25,000 shares - Stock Titan
Price to book forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Enterprise value to revenue forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals (ADIL) Gains 1.17% as Shares Approach Key Resistance LevelMFI Oversold - dars.gov.et
Coastlands Capital details ADIAL Pharmaceuticals (ADIL) stock and warrant stake - Stock Titan
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):